Comparison of Intraocular Pressure Measurements Between Reichert Tono-Vera Tonometer and Goldmann Tonometry
NCT ID: NCT04360369
Last Updated: 2022-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
61 participants
INTERVENTIONAL
2020-10-19
2021-04-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices
NCT05523622
Goldmann Applanation Tonometry, Dynamic Contour Tonometry, and Corvis ST Tonometer
NCT02624427
Effect of Central Corneal Thickness On IOP Using Various Tonometers
NCT00570791
Water Drinking Test and Its Reproducibility in Goldmann Applanation Tonometry and Pneumatic Tonometry
NCT03014349
Reliability and Reproducibility of the Eye Check Tonometer
NCT04639947
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Goldmann Applanation Tonometer
Measurement of IOP with Goldmann Applanation Tonometer. All subjects will participate in this arm.
IOP with Goldmann Applanation Tonometer
Measurement of intraocular pressure (IOP) with Goldmann Applanation Tonometer. Measurement will be used to categorize each subject as having Low IOP (7 to 16 mmHg), Medium IOP (\>16 to \<23 mmHg), or High IOP (\>23 mmHg).
ORA G3 and ic100
Measurement of IOP with Ocular Response Analyzer G3 and ic100 tonometers. All subjects will participate in this arm.
IOP with comparator ORA G3 and ic100 tonometers
Measurement of IOP with Ocular Response Analyzer G3 and ic100 tonometers.
Tono-Vera Tonometer
Measurement of IOP with Tono-Vera Tonometer. All subjects will participate in this arm.
IOP with Tono-Vera Tonometer
Measurement of IOP with Tono-Vera Tonometer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IOP with Goldmann Applanation Tonometer
Measurement of intraocular pressure (IOP) with Goldmann Applanation Tonometer. Measurement will be used to categorize each subject as having Low IOP (7 to 16 mmHg), Medium IOP (\>16 to \<23 mmHg), or High IOP (\>23 mmHg).
IOP with comparator ORA G3 and ic100 tonometers
Measurement of IOP with Ocular Response Analyzer G3 and ic100 tonometers.
IOP with Tono-Vera Tonometer
Measurement of IOP with Tono-Vera Tonometer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be able and willing to provide signed informed consent
* Be able to follow study instructions
Exclusion Criteria
* Subjects with one eye having poor or eccentric fixation;
* Subjects with central corneal thickness greater than 600 µm or less than 500 µm (about 2 standard deviations the human mean);
* Subjects with corneal scarring or who have had corneal surgery, including corneal laser surgery;
* Subjects with concomitant ocular diseases such as: microphthalmos, buphthalmos, nystagmus, keratoconus, severe dry eye syndrome, blepharospasm, any other corneal or conjunctival pathology or infection;
* Contact lens wearers;
* Known allergy to proparacaine or fluorescein as these are used to anesthetize the eye and allow IOP measurement, respectively, when used with the GAT.
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Reichert, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henry Tseng, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Opthalmology, Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ophthalmology, Duke University
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16305-TPR-28
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.